Abstract
Herpes simplex viruses (HSV) belong to a family of over 70 viruses—Herpesviridae— which have the following main characteristics: They consist of a core surrounded successively by an icosadeltahedral capsid, a globular tegument, and an envelope derived primarily from the nuclear membrane. There are two distinct serotypes of herpes simplex viruses (HSV-1 and HSV-2) which can be differentiated by serological, biological, and biochemical means and which share about half their base sequences [151].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ades, E. W., Dougherty, P., Shore, S. L., and Balch, C. M., 1979, E-rosette receptors induced by phytohemagglutinin on human K cells expressing T-cell surface antigens. Cell Immunol. 44:179–185.
Adler, R., Glorioso, J. C., Cossman, J. C., and Levine, M., 1978, Possible role of Fc receptors on cells infected and transformed by herpesvirus: Escape from immune cytolysis. Infect. Immun. 21:441–447.
Allen, J. A., Cooper, C., Daniels, C. A., and Trofatter, K. F., 1978, The effect of prednisolone on antibody-dependent cell-mediated cytotoxicity and the growth of type 1 herpes simplex virus in human cells. Infest. Ophthalmol. Vis. Sci. 17:381–384.
Allison, A. C., 1974, Interaction of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant. Rev. 19:3–55.
Amstey, M. S., 1977, Effect of pregnancy hormoneson herpesvirus and other deoxyribonucleic acid viruses. Am, J. Obstet. Gynecol. 129:159–163.
Anzai, T., Dreesman, G. R., Courtney, R. J., 1975, Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups, J. Natl. Cancer Inst. 54:1051–1059.
Araby, I. I. E., Chernesky, M. A., Rawls, W. E., and Dent, P. B., 1978, Depressed herpes simplex virus-induced lymphocyte blastogenesis in individuals with severe recurrent herpes infections, Clin. Immunol. Immunopathol. 9:253–263.
Ardenson, S. G., Hamilton, J., and Williams, S., 1950, An attempt to vaccinate against herpes simplex, Aust. J. Exp. Biol. Med. Sci. 28:579–584.
Ashe, W. K., and Notkins, A. L., 1967, Kinetics of sensitization of herpes simplex virus and its relationship to the reduction in the neutralization rate constant. Virology 33:613–617.
Ashe, W. K., Mage, M., Mage, R., and Notkins, A. L., 1968, Neutralization and sensitization of herpes simplex virus with antibody fragments from rabbits of different allotypes, J. Immunol. 101:500–504.
Ashman, R. B., and Nahmias, A. J., 1978, Effect of incubation temperature on mitogen responses of lymphocytes from adult peripheral blood and from cord blood, Clin. Exp. Immunol. 33:319–326.
Aurelian, L., and Strand, B. C., 1976, Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer. Cancer Res. 36:810–820.
Aurelian, L., Smith, M. F., and Cornish, D. J., 1976, IgM antibody to a tumor-associated antigen (Ag- 4) induced by herpes simplex virus type 2: Its use in location of the antigen in infected cells, J. Natl. Cancer Inst. 56:471–477.
Austin, R. M., and Daniels, C. A., 1975, Effect of staphylococcal protein A on complement-potentiated neutralization of herpes simplex virus and immune lysis of virus-infected cells. Infect. Immun. 12:821–827.
Azulay, R. D., Monteiro, E. de F., Cunha, W., and Azulay, E., 1971, Vacinoterapia especifica no herpes simplex (1): Ensaios clinicos no herpes mucocutaneo, O Hospital 80:251–261.
Babiuk, L. A., Wardley, R. C., and Rouse, B. T., 1975, Defense mechanisms against bovine herpesvirus: Relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect. Immun. 12:958–963.
Baker, D. A., and Plotkin, S. A., 1978, Enhancement of vaginal infection in mice by herpes simplex virus type 1 with progesterone, Proc. Soc. Exp. Biol. Med. 158:131–134.
Baron, S., Worthington, M. G., Williams, J., and Gaines, J. W., 1976, Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature (London) 261:505–506.
Baringer, J. R., 1975, Herpes simplex virus infection of nervous tissue in animals and man, Prog. Med. Virol. 20:1–25.
Bauche, R. B., and Spear, P. G., 1979, Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein, J. Virol. 32:779–789.
Bell, R. B., Aurelian, L., and Cohen, G. H., 1978, Proteins of herpesvirus type 2. IV. Leukocyte inhibition responses to type common antigens in cervix cancer and recurrent herpetic infections, Cell. Immunol. 41:86–102.
Ben-Zvi, A., Soffer, D., and Yatziv, S., 1978, Disseminated herpes simplex virus infection in ataxia telangiectasia. Acta Paediatr. Scand. 67:667–670.
Bierman, S. M., 1976, BCG Immunoprophylaxis of recurrent herpes progenitalis, Arch. Dermatol. 112:1410–1415.
Blank, H., and Haines, H. G., 1973, Experimental human reinfection with herpes simplex virus, J. Invest. Dermatol. 61:223–225.
Brier, A. M., Snyderman, R., Mergenhagen, S. E., and Notkins, A. L., 1970, Inflammation and herpes simplex virus: Release of a chemotaxis generating factor from infected cells, Science 170:1104–1106.
Brier, A. M., Wohlenberg, C., Rosenthal, J., Mage, M., and Notkins, A. L., 1971, Inhibition or enhancement of immunological injury of virus-infected cells, Proc. Natl. Acad. Sci. USA 68:3073–3077.
Brown, E. W., Burdash, N. M., Manos, J. P., and Duncan, R. C., 1977, MIF-like activity in non-stimulated and virus-infected cell cultures (abstract), Annual Meeting of the American Society for Microbiology, E185, p. 111.
Bubola, D., and Olivetti, L., 1968, L’intradermoreazione con virus erpetico innattivato. I. Analisi de jattori che influenzano la reasione, G. Ital. Dermatol. 109:363–376.
Buchman, T. G., Roizman, B., and Nahmias, A. J., 1981, Structure of herpes simplex virus DNA and application to molecular epidemiology, Ann. N. Y. Acad. Sci. 354:279–290.
Buddingh, G. J., Schrum, D. I., Lanier, J. C., and Guidry, D. J., 1953, Studies on the natural history of herpes simplex infections, Pediatrics 11:595–610.
Bums, W. H., Billups, L. C., and Notkins, A. L., 1975, Thymus dependence of viral antigens, Nature (London) 256:654–655.
Camacho, A., and Spear, P., 1979, Transformation of hamster embryo fibroblasts by a specific fragment of herpes simplex virus genome. Cell 15:993–1002.
Cappel, R., 1976, Comparison of the humoral and cellular immune responses after immunization with live, UV-inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunization, Arch. Virol. 52:29–35.
Carmichael, L. E., Barnes, F. O., and Perez, D. H., 1970, Temperature as a factor in resistance of young puppies to canine herpesvirus, J. Infect. Dis. 120:669–673.
Carritt, B., and Goldfarb, P., 1976, A human chromosomal determinant for susceptibility to herpes simplex virus. Nature (London) 264:556–558.
Catalano, L. W., London, W. T., Rice, J. M., and Sever, J. L., 1972, Prophylactic and therapeutic use of poly (I) Poly (C) [Poly-D-lysine] against herpesvirus encephalitis in mice, Proc. Soc. Exp. Biol. Med. 140:66–71.
Centifanto, Y. M., Drylie, D. M., Deardourff, S. L., and Kaufman, H., 1972, Herpesvirus type 2 in the male genitourinary tract, Science 178:318–319.
Centifanto, Y. M., Little, J. M., and Kaufman, H. E., 1970, The relationship between virus chemotherapy, secretory antibody formation, and recurrent herpetic disease, Ann. N.Y. Acad. Sci. 173:649–656.
Centifanto, Y. M., Zam, Z. S., and Kaufman, H. E., 1977, In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes, Infect. Immun. 17:350–355.
Cheeseman, S. H., Rubin, R. H., Stewart, J. A., Tolkoff-Rubin, N. E., Cosimi, A. B., Cantell, K., Gilbert, J., Winkle, S., Herrin, J. T., Black, P. H., Russell, P. S., and Hirsch, M. S., 1979, Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation, N. Engl. J. Med. 300:1345–1349.
Ching, C., and Lopez, C., 1979, Natural killing of herpes simplex virus type 1-infected target cells: Normal human responses and influence of antiviral antibody, Infect. Immun. 26:49–56.
Chipps, B. E., Saulsbury, F. T., Hsu, S. H., Hughes, W. H., Winkelstein, J. A., 1979, Non-candidal infections in children with chronic mucocutaneous candidiasis, Johns Hopkins Med. J. 144:175–179.
Christenson, B., and Espmark, A., 1976, Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of herpes simplex virus infected cells, Int. J. Cancer 17:318–325.
Christenson, B., 1978, Antibody-dependent cell-mediated cytotoxicity to herpes simplex virus type 2 infected target cells in the course of cervical carcinoma, Am. J. Epidemiol. 108:126–135.
Clancy, R., Rawls, W. E., and Jagannath, S., 1977, Appearance of cytotoxic cells within the bronchus after local infection with herpes simplex virus, J. Immunol. 119:1102–1105.
Cooper, N. R., Jensen, F. C., Welsh, R. M., and Oldstone, M. B. A., 1976, Lysis of RNA tumor viruses by human serum: Direct antibody-independent triggering of the classical complement pathway, J. Exp. Med. 144:970–981.
Corey, L., Reeves, W. C., and Holmes, K. K., 1978, Cellular immune responses in genital herpes simplex virus infection, N. Engl. J. Med. 299:986–991.
Costa, J. C., and Rabson, A. S., 1975, Role of Fc receptors in herpes simplex virus infection. Lancet 1:77–78.
Costa, J., Rabson, A. S., Yee, C., and Tralka, T. S., 1977, Immunoglobulin binding to herpes virus-induced Fc receptors inhibits virus growth. Nature (London) 269:251–252.
Cromeans, T. L., Milgrom, H., and Shore, S. L., 1979, Antibody-dependent cellular cytotoxicity in high concentrations of human serum (abstract). Annual Meeting of American Society for Microbiology, E27, p. 59.
Daniels, C. A., Kleinerman, E. S., and Snyderman, R., 1978, Abortive and productive infection of human mononuclear phagocytes by type 1 herpes simplex virus. Am. J. Pathol. 91:119–36.
Daniels, C. A., Borsos, T., Rapp, H. J., Snyderman, R., and Notkins, A. L., 1970, Neutralization of sensitized virus by purified components of complement, Proc. Natl. Acad. Sci. USA 65:528–535.
Daniels, C. A., LeGoff, S. G., and Notkins, A. L., 1975, Shedding of infections virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Lancet 2:524–528.
Davis, L. E., and Johnson, R. T., 1979, An explanation for the localization of herpes simplex encephalitis, Ann. Neurol. 5:2–5.
Day, R. P., Bienenstock, J., and Rawls, W. E., 1976, Basophil-sensitizing antibody response to herpes simplex viruses in rabbits, J. Immunol. 117:73–78.
de la Pena, N. C., Diaz, A., Damel, A., Bal, E., Puricelli, L., Ejden, J., and deLustig, E. S., 1978, Combined therapy of human interferon (HI) and secretory immunoglobulin (S-IgA) in the treatment of humans herpetic keratitis, Biomedicine 28: 104–108.
Denman, A. M., Pelton, B. K., Appleford, D., and Kinsley, M., 1976, Virus infections of the lymphoreticular cells and auto-immune diseases. Transplant Rev. 31:79–115.
Denman, A. M., Rager-Zisman, B., Merigan, T. C., and Tyrrell, D. A. J., 1974, Replication or inactivation of different viruses by human lymphocyte preparations. Infect. Immun. 9:373–376.
Doerr, H. W., Gross, G., and Schmitz, H., 1976, Neutralizing serum IgM antibodies in infections with herpes simplex virus hominis, Med. Microbiol. Immunol. 162:183–192.
Douglas, R. G., Jr., and Couch, R. B., 1970, A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans, J. Immunol. 104:289–295.
Duff, R., Doller, E., and Rapp, F., 1973, Immunologic manipulation of metastases due to herpesvirus transformed cells. Science 180:79–81.
Duff, R., and Rapp, F., 1971, Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2, J. Virol. 8:469–477.
Dunnick, J. K., and Galasso, G. J., 1979, Clinical trials with exogenous interferon—Summary of a meeting, J. Infect. Dis. 139:109–112.
Ennis, F. A., 1973, Host defense mechanisms against herpes simplex virus. Infect. Immun. 7:898–904.
Ennis, F. A., 1973, Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells, J. Infect. Dis. 127:632–638.
Ennis, F. A., and Wells, M., 1974, Immune control of herpes simplex virus infections, Cancer Res. 34:1140–1145.
Fadnes, H. O., 1975, Protein concentration and hydrostatic pressure in subcutaneous tissue of rats in hypoproteinemia, Scand. J. Clin. Lab. Invest. 35:441–446.
Fanta, D., Topaloglon, A., and Altmann, H., 1978, Studies on the DNA-excision repair in lymphocytes of patients with recurrent herpes simplex, Bull. Cancer 65:341–346.
Flanagan, J. F., 1966, Hydrolytic enzymes in KB cells infected with poliovirus and herpes simplex virus, J. Bacteriol. 91:789–797.
Flewett, T. H., Parker, R. G. F., and Philip, W. M., 1969, Acute hepatitis due to herpes simplex virus in an adult, J. Clin. Pathol. 22:60–66.
Forghani, B., Klassen, T., and Baringer, J. R., 1977, Radioimmunoassay of herpes simplex virus antibody: Correlation with ganglionic infection, J. Gen. Virol. 36:371–375.
Frank, U., Schindling, B., Lindermann, J., and Falke, D., 1978, Multiplication of herpes simplex virus types 1 and 2 in macrophages of NMRI and C57/BL mice, Acta Virol. 22:193–202.
Fritz, M. E., and Nahmias, A. J., 1972, Reversed polarity in transmembrane potentials of cells infected with herpesviruses, Proc. Soc. Exp. Biol. Med. 139:1159–1161.
Fujibayashi, T., Hooks, J. J., and Notkins, A. L., 1975, Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes, J. Immunol. 115:119–193.
Fujimiya, Y., Rouse, B. T., and Babiuk, L. A., 1978, Human neutrophil-mediated destruction of antibody sensitized herpes simplex virus type 1 infected cells. Can. J. Microbiol. 24:182–186.
Galloway, D. A., Fenoglio, C., Shevcuk, M., and McDougall, J. K., 1979, Detection of herpes simplex RNA in human sensory ganglia. Virology 95:265–268.
Gange, R. W., DeBats, A., Park, J. R., Bradstreet, C. M. P., and Rhodes, E. L., 1975, Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpes simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation, Br. J. Dermatol. 97:539–544.
Glasgow, L. A., and Habel, K., 1963, Role of polyoma virus and interferon in a herpes simplex infection in vitro, Virology 19:328–339.
Glezen, W. P., Fernald, G. W., and Lohr, J. A., 1975, Acute respiratory disease of university students with special reference to the etiologic role of herpesvirus hominis, Am. J. Epidemiol. 101:111–121.
Glorioso, J., and Smith, J. W., 1977, Immune interactions with cells infected with herpes simplex virus: Antibodies to radioiodinated surface antigens, J. Immunol. 118:114–121.
Godfrey, R. C., 1972, Resistance to intracerebral challenge in mice immunized against herpes simplex virus, Br. J. Exp. Pathol. 53:529–538.
Goldman, L., 1961, Reactions of autoinoculation from recurrent herpes simplex. Arch. Dermatol. 84:1025–1026.
Gordon, D. S., and Shore, S. L., 1980, Antibody-dependent cellular cytotoxicity to virus-infected target cells: Role of nylon wool-adherent T cells as effectors, Cell. Immunol. 50:19–29.
Gresser, I., Tovey, M. G., Bandu, M. T., Maury, C., and Brouty-Boye, D., 1976, Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum, J. Exp. Med. 144:1305–1323.
Guerra, R., Galin, M. A., and Frezotte, R., 1977, Use of interferon in eye infections in man, Texas Rep. Biol. Med. 35:497–502.
Haahr, S., Rasmussen, L., and Merigan, T. C., 1976, Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus. Infect. Immunol. 14:47–54.
Hampar, B., Notkins, A. L., Mage, M., and Keehn, M. A., 1968, Heterogenicity in the properties of 7 S and 19 S rabbit-neutralizing antibodies to herpes simplex virus, J. Immunol. 100:586–593.
Hill, T. J., and Blyth, W. A., 1976, An alternative theory of herpes simplex recurrence and a possible role for prostaglandins. Lancet 1:397–398.
Hilleman, M., and Larson, V., 1979, Comments at Proceedings of the Experimental Herpesvirus Vaccine Workshop, FDA, BOB (February 9, 1979).
Hirsch, M. S., Zisman, B., and Allison, A. C. 1970, Macrophages and age-dependent resistance to herpes simplex virus in mice, J. Immunol. 104:1160–1165.
Hollinshead, A. C., Chretien, P. B., Lee, O’B., Tarpley, J. L., Kerney, S. E., Silverman, N. A., and Alexander, J. C., 1976, In vivo andin vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens. Cancer Res. 36:821–828.
Honess, R. W., and Watson, D. H., 1977, Unity and diversity in the herpesviruses, J. Gen. Virol. 37:15–24.
Hurwitz, E., Zatz, M. M., and Segal, D. M., 1977, The biological activity of affinity cross-linked oligimers of rabbit immunoglobulin G as tested by antibody-dependent cell-mediated cytolysis (ADCC), J. Immunol. 118:1348–1353.
Ibrahim, A. N., Ray, M., Megaw, J., Brown, R., and Nahmias, A. J., 1976, Common antigens of herpes simplex virus 2, associated hamster tumors, and human cervical cancer, Proc. Soc. Exp. Biol. Med. 152:343–347.
Ida, S., Hooks, J. J., Siraganian, R. P., and Notkins, A. L., 1977, Enhancement of IgE mediated histamine release from human basophils by viruses: Role of interferon, J. Exp. Med. 145:892–906.
Ito, H., Tsutsui, F., Kurihara, S., Akabayashi, T., Tobe, T., and Nishimura, C., 1976, Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique. Int. J. Cancer 18:557–563.
Jacobs, R. P., Aurelian, L., and Cole, G. A., 1976, Cell-mediated immune response to herpes simplex virus: Type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection, J. Immunol. 116:1520–1525.
Johnson, R. T., 1964, The pathogenesis of herpes virus encephalitis. II. A cellular basis for the development of resistance with age, J. Exp. Med. 120:359–373.
Juretic, M., 1966, Natural history of herpetic infection, Helv. Paediat. Acta 21:355–368.
Kalimo, K. O. K., Marttila, R. J., Granfors, K., and Viljanen, M. K., 1976, Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens, Infect. Immun. 15:883–889.
Kawana, T., Cornish, J. D., Smith, M. F., and Aurelian, L., 1976, Frequency of antibody to a virus-induced, tumor-associated antigen (Ag-4) in Japanese sera from patients with cervical cancer and controls. Cancer Res. 36:1910–1914.
Keddie, F. M., Rees, R. B., and Epstein, N. N., 1941, Herpes simplex following artificial fever therapy, J. Am. Med. Assoc. 117:1327–1330.
Kern, A. B., and Scheff, B. L., 1959, Smallpox vaccination in the management of recurrent herpes simplex: A controlled evaluation, J. Invest. Dermatol. 33:99–102.
Kirchner, H., Hurt, H. M., Kleincke, C., and Münk, K., 1976, Replication of herpes simplex virus in mouse spleen cell culture stimulated by lipopolysaccharides, J. Immunol. 117:1753–1756.
Kirchner, H., Zawatzky, R., and Hirt, H. M., 1978, In vitro production of immune interferon by spleen cells of mice immunized with herpes simplex virus.Cell. Immunol. 40:204–210.
Kitces, E. N., Morahan, P. S., Tew, J. G., and Murray, B. K., 1977, Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Infect. Immun. 16:955–960.
Klein, R., 1976, Latency of herpes simplex virus. Arch. Virol. 51:1–13.
Kleinerman, E. S., Snyderman, R., and Daniels, C. A., 1974, Depression of human monocyte chemotaxis by herpes simplex and influenza viruses, J. Immunol. 113:1562–1567.
Kleinman, L. F., Kibrick, S., Ennis, F., and Polgar, P., 1972, Herpes simplex virus replication in human lymphocyte culture stimulated with phytomitogehs and anti-lymphocyte globulin, Proc. Soc. Exp. Biol. Med. 141:1095–1099.
Kohl, S., Cahall, D. L., Walters, D. L., and Schaffner, V. E., 1979, Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells, J. Immunol. 123:25–30.
Kohl, S., Pickering, L. K., Sullivan, M. P., Walters, D. L., 1980, Impaired monocyte-macrophage cytotoxicity in patients with Hodgkin’s disease, Clin. Immunol. Immunopathol. 15:577–585.
Kohl, S., Malloy, M. M., Pickering, L. K., Morriss, F. H., Adcock, E. W., and Walter, D. L., 1978, Human colostral cytotoxicity. I. Antibody-dependent cellular cytotoxicity against herpes simplex viral-infected cells mediated by colostral cells, J. Clin. Lab. Immunol. 1:221–224.
Kohl, S., Shaban, S. S., Starr, S. E., Wood, P. A., and Nahmias, A. J., 1978, Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex, J. Pediatr. 93:206–210.
Kohl, S., Starr, S. E., Oleske, J. M., Shore, S. L., Ashman, R. B., and Nahmias, A. J., 1977, Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells, J. Immunol 118:729–735.
Krueger, G. G., Spruance, S. L., and Overall, J. C., 1978, Herpes simplex labialis — A review of pathogenesis, natural history and therapy, J. C. E. Dermatology 7:19–88.
Kurata, T., Kurata, K., and Aoyama, Y., 1978, Vertical transmission of type 2 herpes simplex virus in immunosuppressed hamsters, Jpn. J. Exp. Med. 48:437–443.
Kurtz, J. B., 1974, Specific IgG and IgM antibody responses in herpes simplex infections, J. Med. Microbiol. 7:333–341.
Larson, C. L., Ushijima, R. N., and Karen, R., 1972, Herpesvirus hominis type 2 infection in rabbits: Effect of prior immunization with attenuated Mycobacterium bovis (BCG), Infect. Immun. 6: 465–468.
Lausch, R. N., Sawyers, J. S., and Kaufman, H. E., 1966, Delayed hypersensitivity to herpes simplex virus in the guinea pig, J. Immunol. 96:981–987.
Lawman, M. J. B., Rouse, B. T., and Courtney, R. J., 1980, Cell mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect. Immun. 27:133–139.
Lerner, A. M., Shippey, M. J., and Crane, L. R., 1974, Serologic responses to herpes simplex virus in rabbits: Complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies, J. Infect. Dis. 129:623–636.
Linnemann, C. C., May, D. B., Schubert, W. K., Caraway, C. T., and Schiff, G. M., 1973, Fatal viral encephalitis in children with x-linked hypogammaglobulinemia, Am. J. Dis. Child, 126: 100–103.
Lodmell, D. L., Niwa, A., Hayashi, K., and Notkins, A. L., 1973, Prevention of cell-to-cell spread of herpes simplex virus by leukocytes, J. Exp. Med. 137:706–720.
Lodmell, D. L., and Notkins, A. L., 1974, Cellular immunity to herpes simplex virus mediated by interferon, J. Exp. Med. 140:764–778.
London, W. T., Catalano, L. W., Nahmias, A. J., Fuccillo, D. A., and Sever, J. L., 1971, Genital herpesvirus type 2 infection of monkeys, Obstet. Gynecol. 37:501–509.
Lopez, C., 1975, Genetics of natural resistance to herpesvirus infections in mice. Nature (London) 258:152–153.
Lopez, C., 1978, Genetic resistance to HSV-1 in the mouse is mediated by the “M” cell of allogeneic resistance. Fed. Proc. 37:1560.
Lopez, C., and Dudas, G., 1979, Replication of herpes simplex virus type 2 in macrophages from resistant and susceptible mice. Infect. Immun. 23:432–437.
Lopez, C., and O’Reilly, R. J., 1977, Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay, J. Immunol. 118:895–902.
Luyet, F., Samra, D., Soneji, A., and Marks, M. I., 1975, Passive immunization in experimental herpesvirus hominis infection of newborn mice. Infect. Immun. 12:1258–1261.
McClung, H., Seth, P., and Rawls, W. E., 1976, Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of herpes simplex virus types 1 and 2, Am. J. Epidemiol. 104:192–201.
McDougall, J. K., Galloway, D. A., and Fenoghio, C. M., 1980, Cervical carcinoma: Detection of herpes simplex virus RNA in cells undergoing neoplastic changes. Int. J. Cancer 25:1–8.
McKendell, R. R., Klassen, T., and Baringer, J. R., 1979, Host defenses in herpes simplex infections of the nervous system: Effect of antibody on disease and viral spread, Infect. Immun. 23:305–311.
Melewicz, F. M., Shore, S. L., Ades, E. W., and Philllips, D. J., 1977, The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell, J. Immunol. 118:567–573.
Metcalf, J. F., Hamilton, D. S., and Reichert, R. W., 1979, Herpetic keratitis in athymic (nude) mice. Infect. Immun. 26:1164–1171.
Meyers, R., 1976, Immunology of herpes simplex. Survey Ophthalm. 21:194–204.
Meyers, R. L., and Pettit, J. H., 1973, The pathogenesis of corneal inflammation due to herpes simplex virus. I. Corneal hypersensitivity to HSV antigens in the rabbit, J. Immunol. 111:1031–1042.
Milgrom, H., and Shore, S. L., 1977, Assessment of monocyte function in the normal newborn infant by antibody-dependent cellular cytotoxicity, J. Pediatr. 91:612–614.
Miller, M. E., and Stiehm, E. R. (eds.), 1979, Symposium on host defenses in the fetus and neonate. Pediatrics 64(Suppl.):705–833.
Mills, B. J., and Cooper, N. R., 1978, Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements, J. Immunol. 121:1549–1557.
Mintz, L., Drew, W. L., Hoo, R., and Finley, T. R.,1978, Growth of herpes simplex virus in human alveolar macrophages (abstract). Annual Meeting of the American Society for Microbiology, p. 253.
Mochizuki, D., Hedrick, S., Watson, J., and Kingsbury, D. T., 1977, The interaction of herpes simplex virus with murine lymphocytes. 1. Mitogenic properties of herpes simplex virus, J. Exp. Med. 146:1500–1510.
Mogensen, S. C., 1977, Genetics of macrophage-controlled resistance to hepatitis induced by herpes simplex virus type 2 in mice, Infect. Immun. 17:268–273.
Mogensen, S. C., 1978, Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 in mice. Infect. Immun. 19:46–50.
Mogensen, S. C., and Anderson, H. K., 1977, Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice. Infect. Immun. 17:274–277.
Mogensen, S. C., and Anderson, H. K., 1978, Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2, Infect. Immun. 19:792–798.
Møller-Larsen, A., Haahr, S., and Black, F. T., 1978, Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis, Infect. Immun. 22:445–457.
Møller-Larsen, A., Heron, I., and Haahr, S., 1977, Cell-mediated cytotoxicity to herpes-infected cells in humans: Dependence on antibodies. Infect. Immun. 16:43–47.
Morahan, P. S., Breinig, M. C., and McGeorge, M. B., 1977, Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2, J. Immunol. 119:2030–2036.
Morahan, P. S., Glasgow, L. A., Crane, J. L., Jr., and Kern, E. R., 1977, Comparison of antiviral and antitumor activity of activated macrophages. Cell. Immunol. 28:404–415.
Morahan, P. S., Morse, S. B., McGeorge, M. B., 1979, Macrophage extrinsic antiviral activity during herpes simplex virus infection, J. Gen. Virol. 46:291–300.
Morahan, P. S., Kern, E. R., and Glasgow, L. A., 1977, Immunomodulator-induced resistance against herpes simplex virus, Proc. Soc. Exp. Biol. Med. 154:615–620.
Mori, R., Tasaki, T., Kimura, G., and Takeya, K., 1967, Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice. Arch. Ges. Virusforsch. 2: 459–462.
Muller, S. A., Herrmann, E. C., and Winkelmann, R. K., 1972, Herpes simplex infection sin hematologic malignancies. Am. J. Med. 52:102–114.
Nahmias, A., 1974, The evolution (evovirology) of herpesviruses, in: Viruses, Evolution and Cancer (E. Kurstak and K. Maramorosch, eds.), pp. 605–622, Academic Press, New York.
Nahmias, A., 1977, The laboratory diagnosis of herpes simplex virus infections — Prospects and problems, Diag. Horizons 1:1–7.
Nahmias, A. J., and Ashman, R. B., 1978, The immunology of primary and recurrent herpesvirus infection—An overview, in:Oncogenesis and Herpesviruses III (G. deThé and F. Rapp, eds.). pp. 659–674, International Agency for Research on Cancer, Lyon, France.
Nahmias, A. J., and Ashman, R. B., 1979, Herpes simplex virus-associated antigens, in: Immunodiagnosis of Cancer, Part II (R. Herberman and K. R. Mclntire, eds.), pp. 857–874, Dekker, New York.
Nahmias, A., and Dowdle, W., 1968, Antigenic and biologic differences in herpesvirus hominis. Prog. Med. Virol. 10:119–159.
Nahmias, A. J., and Josey, W. E., 1981, Epidemiology of herpes simplex virus 1 and 2, in:Viral Infections of Humans: Epidemiology and Control (A. Evans, ed.). Plenum Medical, New York, (in press).
Nahmias, A., and Norrild, B., 1979, Herpes simplex viruses 1 and 2—Basic and clinical aspects, Disease-a-Month 25(10):5–49.
Nahmias, A., and Norrild, B., 1980, The oncogenic potential of herpes simplex viruses and their association with cervical neoplasia, in: Oncogenic Herpesviruses (F. Rapp, ed.), CRC Press, Boca Raton pp. 25–46.
Nahmias, A., and Roizman, B., 1973, Herpes simplex viruses, N. Engl. J. Med. 289:667–674; 719–725.
Nahmias, A., and Starr, S., 1977, Infections caused by herpes simplex virus, in: Infectious Diseases (P. Hoeprich, ed.), pp. 726–735, Harper & Row, New York.
Nahmias, A., and Visintine, A., 1976, Herpes simplex, in: Infectious Diseases of the Fetus and Newhorn Infant (J. Remington and J. Klein, eds.), pp. 156–190, Saunders, Philadelphia, Pennsylvania.
Nahmias, A., and Visintine, A., 1979, Liver involve ment in neonatal herpes simplex virus infection, in:Neonatal Hepatitis and Biliary Atresia (N. Javitt, ed.), DHEW Publication No. (NIH) 79–1296, pp. 47–54.
Nahmias, A., and Whitley, R., 1981, Herpes simplex virus encephalitis in newborns and children, Ped. Rev. 2:259–266.
Nahmias, A. J., Kibrick, S., and Rosan, R. C., 1964, Viral leukocyte interrelationships. I. Multiplication of a DNA virus—herpes simplex — in human leukocyte cultures, J. Immunol. 93:69–74.
Nahmias, A. J., Naib, Z. M., Josey, W. E., and Clepper, A. C., 1967, Herpes simplex infection of the female genital tract: Virological and cytological studies. Obstet. Gynecol. 29:395–400.
Nahmias, A. J., Dowdle, W. R., Naib, Z. M., Josey, W. E., Painter, L., and Luce, C., 1969, Newborn infection with Herpesvirus hominis types 1 and 2, J. Pediat. 75:1194–1203.
Nahmias, A. J., Hirsch, M. S., Kramer, J. H., and Murphy, F. A., 1969, Effect of antithymocyte serum on herpesvirus hominis (type 2) infection in aduh mice, Proc. Soc. Exp. Biol. Med. 132:696–698.
Nahmias, A. J., Josey, W. E., Naib, Z. M., Luce, C. P., and Duffey, A., 1970, Antibodies to herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections, Am. J. Epidemiol. 91:539–552.
Nahmias, A., Naib, Z., and Josey, W., 1974, Epidemiological studies relating genital herpes to cervical cancer, Cancer Res. 34:1111–1117.
Nahmias, A., Ibrahim, I., and Del Buono, I., 1975, Antigenic relationship between herpes simplex viruses, human cervical cancer and HSV-associated hamster tumors, in: Oncogenesis and Herpesviruses II (G. deThé, M. Epstein, and H. Zur Hausen, eds.), pp. 309–313, International Agency for Research on Cancer, Scientific Publications No. 11, Lyon, France.
Nahmias, A., Norrild, B., Vestergaard, B., Muther, J., Naib, Z., and Josey, W., 1978, Does HSV-1 prevent HSV-2 associated cervical neoplasia as turkey HV does MDV tumors? Abstract, 4th International Congress for Virology, The Hague, The Netherlands (Sept. 1978).
Nahmias, A., Whitley, R., Visintine, A., Dannenbarger, J., Wickliffe, C., and Alford, C., 1981, Laboratory aspects of neonatal herpes simplex virus infections (submitted for publication).
Nakamura, Y., Costa, J., Tralka, T. S., Yee, C. L., and Rabson, A. S., 1978, Properties of the cell surface Fc-receptor induced by herpes simplex virus, J. Immunol. 121:1128–1131.
Naraqui, S., Jackson, G. G., and Jonasson, O. M., 1976, Viremia with herpes simplex type 1 in adults—four non-fatal cases, one with features of chickenpox, Ann. Int. Med. 85:165–169.
Naraqui, S., Jonasson, O., Jackson, G. G., and Yamashiroya, H. M., 1978, Clinical manifestations of infections with herpesviruses after kidney transplantation: A prospective study of various syndromes, Ann. Surg. 188:234–239.
Neff, J. M., and Lane, J. M., 1970, Vaccinia necrosum following smallpox vaccination for chronic herpetic ulcers, J. Am. Med. Assoc. 213:123–125.
Norrild, B., Shore, S. L., and Nahmias, A. J., 1979, Herpes simplex virus glycoproteins: Participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides, J. Virol. 32:741–748.
Notkins, A. L., 1971, Infectious virus antibody complexes: Interaction with anti-immunoglobulins, complement, and rheumatoid factor, J. Exp. Med. 134:419–519.
Notkins, A. L., 1974, Immune mechanisms by which the spread of viral infections is stopped, Cell. Immunol. 11:478–483.
Notter, M. F. D., and Docherty, J. J., 1976, Comparative diagnostic aspects of herpes simplex tumor-associated antigens, J. Natl. Cancer Inst. 57:483–488.
Oakes, J. E., 1975, Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect. Immun. 12:166–172.
Oakes, J. E., and Rosemond-Hornbeak, H., 1978, Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infect. Immun. 21:489–495.
Oleske, J. M., Ashman, R. B., Kohl, S., Shore, S. L., Starr, S. E., Wood, P. A., and Nahmias, A. J., 1977, Human polymorphonuclear leukocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simple virus-infected cells, Clin. Exp. Immunol. 27:446–453.
Oleske, J. M., Starr, S. E., Kohl, S., and Nahmias, A. J., 1978, Clinical evaluation of transfer factor in patients with recurrent herpes simplex virus infections, in: Current Chemotherapy Proceedings of the 10th International Congress of Chemotherapy, Vol. 1, pp. 359–360, American Society for Microbiology, Washington, D.C.
Olson, G. B., 1973, Effect of various viruses on the responsiveness of mouse lymphocytes to phytohemagglutinin stimulation. Infect. Immun. 7: 438–444.
O’Reilly, R. J., Chibbaro, A., Anger, E., and Lopez, C., 1977, Cell-mediated immune responses in patients with recurrent herpes simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis, J. Immunol. 118: 1095–1102.
Pacsa, A. S., Kummerlander, L., Pejtsik, B., Krommer, K., and Pali, K., 1976, Herpes simplex virus- specific antigens in exfoliated cervical cells from women with and without cervical anaplasia. Cancer Res. 36:2130–2132.
Para, M. F., Baucke, R. B., and Spear, P. G., 1980, Immunoglobulin G (Fc)-binding receptors on virions of HSV type 1 and transfer of these receptors to the cell surface by infection, J. Virol. 34:512–520.
Pass, R. F., Whitley, R. J., Whelchel, J. D., Diethelm, A. G., Reynolds, D. W., and Alford, C. A., 1980, Identification of renal transplant patients with increased risk of postoperative herpes simplex virus infection, J. Infect. Dis. 140:487–492.
Pavan, P. R., and Ennis, F. A., 1977, The elimination of herpes simplex plaques by antibody and the emergence of resistant strains, J. Immunol. 118:2167–2175.
Pazin, G. J., Armstrong, J. A., Lam, M. T., Tarr, G. C., and Jannetta, P. J., and Ho, M., 1979, Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root, N. Engl. J. Med. 301:205–209.
Peck, B., personal communication.
Pelton, B. K., Imrie, R. C., and Denman, A. M., 1977, Susceptibility of human lymphocyte populations to infection by herpes simplex virus, Immunology 32:803–810.
Pereira, L., Cassai, E., Honess, R., Roizman, B., Terni, M., and Nahmias, A., 1976, Variability in the structural polypeptides of herpes simplex virus strains: Potential application in molecular epidemiology, Infect. Immun. 13:211–220.
Perrin, L. H., Joseph, B. S., Cooper, N. R., and Oldstone, M. B. A., 1976, Mechanism of injury of virus-infected cells by antiviral antibody and complement: Participation of IgG, F(ab′)2, and the alternative complement pathway, J. Exp. Med. 143:1027–1041.
Pfizenmaier, K., Jung, H., Starzinski-Powitz, A., Rollinghoff, M., and Wagner, H., 1977, The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes, J. Immunol. 119:939–944.
Piontek, G. E., Weltzin, R., and Tompkins, W. A. F., 1980, Enhanced cytotoxicity of mouse natural killer cells for vaccinia and herpes virus-infected targets, J. Reticuloendothel. Soc. 27:175–188.
Plaeger-Marshall, S., and Smith, J. W., 1978, Experimental infection of subpopulations of human peripheral blood leukocytes by herpes simplex virus, Proc. Soc. Exp. Biol. Med. 158:263–268.
Pollikoff, R., Cannavale, P., and Dixon, P., 1972, Herpes simplex virus infection in rabbit eye. Arch. Ophthal. 88:52–57.
Price, R., Chernick, N. L., Horta-Barbosa, L., and Posner, J. B., 1973, Herpes simplex encephalitis in an anergic patient. Am. J. Med. 54:222–228.
Price, W., and Schmitz, J., 1979, Route of infection, systemic host resistance, and integrity of ganglionic axons influence acute and latent herpes simplex virus infection of the superior cervical ganglion, Infect. Immun. 23:373–383.
Rabson, A. R., Whiting, D. A., Anderson, R., Glover, A., and Koornhof, H. J., 1977, Depressed neutrophil motility in patients with recurrent herpes simplex virus infections:In vitro restoration with levamisole, J. Infect. Dis. 135:113–116.
Rager-Zisman, B., and Allison, A. C., 1976, Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection, J. Immunol. 116: 35–40.
Rager-Zisman, B., and Bloom, B. R., 1974, Immunological destruction of herpes simplex virus 1 infected cells, Nature (London) 251:542–543.
Ramsey, P. G., Corey, L., and Meyers, J. D., 1979, Pathogenesis of HSV-1 and HSV-2 pneumonia- Relationship to virus type (abstract #40), 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct. 15, 1979.
Ramshaw, I., 1975, Lysis of herpes virus-infected target cells by immune spleen cells, Infect. Immun. 11:767–769.
Rand, K. H., Rasmussen, L. E., Pollard, R. B., Arvin, A., and Merigan, T. C., 1976, Cellular immunity and herpesvirus infections in cardiac-transplant patients, N. Engl. J. Med. 296:1372–1377.
Rapp, F., and Reed, C., 1976, Experimental evidence for the oncogenic potential of herpes simplex virus. Cancer Res. 36:800–806.
Rasmussen, A. F., and Schmidt, J. R., 1960, The influence of environmental temperature on the course of experimental herpes simplex infection, J. Infect. Dis. 106:356.
Rasmussen, L. E., Jordan, G. W., Stevens, D. A., and Merigan, T. C., 1974, Lymphocyte interferon production and transformation after herpes simplex infections in humans, J. Immunol. 112:728–736.
Rasmussen, L. E., and Merigan, T. C., 1978, Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans, Proc. Natl. Acad. Sci. USA 75:3957–3961.
Rawls, W. E., Bacchetti, S., and Graham, F. L., 1977, Relation of herpes simplex to human malignancy, in: Current Topics in Microbiology and Immunology (W. Arber, W. Henle, and P. H. Hofschneider, eds.), pp. 71–95, Springer-Verlag, Berlin.
Rawls, W. E., and Tompkins, W. A. F., 1975, Destruction of virus-infected cells by antibody and complement, in: Viral Immunology and Immunopathology, (A. L. Notkins, ed.), pp. 99–111, Academic Press, New York.
Reeves, W. C., Corey, L., Vontver, L., and Adams, H., 1979, HSV type—A determinant of recurrent genital herpes (Abstract #38), 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct. 15, 1979.
Reichman, R. C., Dolin, R., Vincent, M. M., and Fauci, A. S., 1977, Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man, Proc. Soc. Exp. Biol. Med. 155:571–576.
Rinaldo, C. R., Jr., Richter, B. S., Black, P. H., Callery, R., Chess, L., and Hirsch, M. S., 1978, Replication of herpes simplex virus and cytomegalovirus in human leukocytes, J. Immunol. 120:130–136.
Roane, P. R., Jr., and Roizman, B., 1964, Studies of the determinant antigens of viable cells. II. Demonstration of altered antigenic reactivity of HEp-2 cells infected with herpes simplex virus. Virology 22:1–8.
Rogers, H. W., Scott, L. V., and Patnode, R. A., 1972, Sensitization of guinea pigs to herpes simplex virus, J. Immunol. 109:801–806.
Roizman, B., 1965, An inquiry into the mechanisms of recurrent herpetic infections of man, Persp. Virol. 4:283–301.
Roizman, B., 1979, The structure and isomerization of the herpes simplex viruses. Cell 16:481–502.
Romano, T. J., and Shore, S.L., 1977, Lysis of virus-infected target cells by antibody dependent cellular cytotoxicity. 1. General requirements of the reaction and temporal relationship between lethal hits and cytolysis. Cell. Immunol. 30:66–81.
Romano, T. J., and Shore, S. L., 1979, Analysis of the adhesion step in the herpes simplex virus antibody-dependent cellular cytotoxicity system. Infect. Immun. 26:163–172.
Rosenberg, G. L., and Notkins, A. L., 1974, Induction of cellular immunity to herpes simplex virus: Relationship to the humoral immune response, J. Immunol. 112:1019–1024.
Rosenberg, G. L., Farber, P. A., and Notkins, A. L., 1972, In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vacinia virus, Proc. Natl. Acad. Sci. USA 69:756–760.
Rosenberg, G. L., Wohlenberg, C., Nahmias, A. J., and Notkins, A. L., 1972, Differentiation of type 1 and type 2 herpes simplex virus by in vitro stimulation immune lymphocytes, J. Immunol. 109:413–414.
Rosenberg, G. L., Snyderman, R., and Notkins, A. L., 1974, Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with herpes simplex virus. Infect. Immun. 10:111–115.
Rosenthal, J., Hayashi, K., and Notkins, A. L., 1973, Virus antigens on the surface of infected cells: Binding and elution of 125I-labelled antivirus antibody, J. Gen. Virol. 18:195–199.
Rouse, B. T., Grewal, A. S., Babiuk, L. A., and Fujimiya, Y., 1977, Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement. Infect. Immun. 18:660–665.
Royston, I., and Aurelian, L., 1970, Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma, Proc. Natl. Acad. Sci. USA 67:204–217.
Rudneva, A., Korabelhikora, N. I., Germanov, A. B., Sokolov, M. I., and Fadeeva, L. I., 1972, Studies of interferogenic activity of herpes simplex virus. Arch. Virusforsch. 37:1–5.
Russell, A. S., 1974, Cell-mediated immunity to herpes simplex virus in man, J. Infect. Dis. 129:142–146.
Russell, A. S., and Essery, G., 1977, Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV-1 infected target cells in disease. Cancer 40: 42–45.
Russell, A. S., and Kaiser, J. T., 1976, Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells, J. Allergy Clin. Immunol. 58:539–545.
Russell, A. S., and Miller, C., 1978, A possible role for polymorphonuclear leukocytes in the defense against recrudescent herpes simplex virus infection in man. Immunology 4:371–378.
Russell, A. S., and Schlaut, J., 1977, Association of HLA-Al antigen and susceptibility to recurrent cold sores. Arch. Dermatol. 113:1721–1722.
Russell, A. S., Percy, J. S., and Kovithavongs, T., 1975, Cell-mediated immunity to herpes simplex in humans: Lymphocyte cytotoxicity measured by 51Cr release from infected cells. Infect. Immun. 11:355–359.
Russell, A. S., Kaiser, J., Lao, V. S., 1976, Cell-mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration, J. Immunol. Meth. 9:273–279.
Saksela, E., Leinikki, P., and Vesterinen, E., 1976, Adenine arabinoside (Ara-A) blocked HSV-2 infected human skin fibroblasts as targets for the detection of serum-mediated and cellular cytotoxicity in patients with cervical carcinoma, Clin. Exp. Immunol. 25:264–269.
Santoli, D., Trinchieri, G., and Koprowski, H., 1978, Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells, J. Immunol. 121:532–538.
Santoli, D., Trinchieri, G., and Lief, F. S., 1978, Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte, J. Immunol. 121:526–538.
Schlabach, A. J., Martinez, D., Field, A. K., and Tytell, A. A., 1979, Resistance of C58 mice to primary systemic herpes simplex virus infection: Macrophage dependence and T-cell independence. Infect. Immun. 26:615–620.
Schlehofer, J. R., Habermehl, K.-O., Diefenthal, W., and Hampl, H., 1979, Reduction of 51Cr- permeability of tissue culture cells by infection with herpes simplex virus type 1, Intervirology 11:158–166.
Schräder, J. W., and Edelman, G. M., 1977, Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatability complex, J. Exp. Med. 145:523–539.
Scriba, M., 1974, Stimulation of peripheral blood lymphocytes by herpes simplex virus in vitro, Infect. Immun. 10:430–436.
Scriba, M., 1975, Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection. Infect. Immun. 12:162–165.
Scriba, M., 1977, Extraneural localisation of herpes simplex virus in latently infected guinea pigs. Nature (London) 1267:529–531.
Scriba, M., 1978, Animal studies on the efficacy of an inactivated herpes simplex virus vaccine against recurrent herpes infections. Infection 6:137–139.
Sethi, K. K., and Brandis, H., 1977, Specifically immune mouse T-cells can destroy H-1 compatible murine target cells infected with herpes simplex virus types 1 and 2, Z. Immun.-Forsch. 150:162–173.
Sethi, K. K., and Brandis, H., 1978, Interferon enhances T cell mediated cytotoxicity of H-2 compatible target cells infected with UV-inactivated herpes simplex virus. Arch. Virol. 57:177–183.
Shelley, W. B., 1967, Herpes simplex virus as a cause of erythema multiforme, J. Am. Med. Assoc. 201:153–156.
Shillitoe, E. J., Wilton, J. M. A., and Lehner, T., 1977, Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans. Infect. Immun. 18:130–137.
Shillitoe, E. J., Wilton, J. M. A., and Lehner, T., 1978, Sequential changes in T and B lymphocyte responses to herpes simplex virus in man, Scand. J. Immunol. 7:357–366.
Shimizu, F., Hanaumi, K., Shimizu, Y., and Kumagai, K., 1977, Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plaque and infective assays, Infect. Immun. 16:531–536.
Shore, S. L., and Romano, T. J., 1980, Analysis of the lytic step in the herpes simplex virus antibody-dependent cellular cytotoxicity system. Infect. Immun. 28:137–146.
Shore, S. L., Cromeans, T. L., and McDougal, J. S., 1979, Lysis of herpes-infected cells early in the infectious cycle by antibody and complement (abstract), Annual Meeting American Society of Microbiology, p. 80.
Shore, S. L., Nahmias, A. J., Starr, S. E., Wood, P. A., and McFarlin, D. E., 1974, Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus, Nature (London) 251:350–352.
Shore, S. L., Cromeans, T. L., and Romano, T. J., 1976, Immune destruction of virus-infected cells early in the infectious cycle. Nature (London) 262:695–696.
Shore, S. L., Cromeans, T. L., and Norrild, B., 1979, Early damage of herpes-infected cells by antibody-dependent cellular cytotoxicity: Relative roles of virus-specified cell surface antigens and input virus, J. Immunol. 123:2239–2244.
Shore, S. L., Black, C. M., Melewicz, F. M., Wood, P. A., and Nahmias, A. J., 1976, Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus, J. Immunol. 116:194–201.
Shore, S. L., Romano, T. J., Hubbard, M. R., and Gordon, D. S., 1977, Lysis of virus-infected target cells by antibody-dependent cellular cytotoxicity. II. Reversibility of the heat inactivation of K cell killing and relationship of Fc receptor capping to lysis, Cell. Immunol. 311:55–61.
Shore, S. L., Milgrom, H., Wood, P. A., and Nahmias, A. J., 1977, Antibody-dependent cellular cytotoxicity to target cells infected with herpes simplex viruses: Functional adequacy in the neonate, Pediatrics 59:22–28.
Shore, S. L., Melewicz, F. M., Gordon, D. S., 1977, The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells, J. Immunol. 118:558–566.
Shore, S. L., Cromeans, T. L., McDougal, J. S., 1979, Lysis of herpes-infected cells as the infectious cycle by antibody and complement, Abstract E(H)16, Annual Meeting of American Society for Microbiology, p. 80.
Siebens, H., Tevethia, S. S., and Babior, B. M., 1979, Neutrophil-mediated antibody-dependent killing of herpes-simplex-virus-infected cells, Blood 54:88–94.
Simmons, R. L., Centifanto, Y., and Kaufman, H. E., 1974, Plaque size reduction as a measure of viral cell-mediated immunity, Infect. Immun. 10:1034–1039.
Skinner, G. R. B., Mushi, E. Z., and Whitney, J. E., 1976, Immune inhibition of virus release from herpes simplex virus-infected cells, Intervirology 6:296–308.
Skinner, G. R. B., Whitney, J. E., and Hartley, C., 1977, Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology; evidence towards pre-pubertal vaccination of seronegative female subjects. Arch. Virol. 54:211.
Skinner, G. R. B., Buchan, W. A., Whitney, J., Harding, M., and Godfish, K., 1978, Preparation and efficacy of an inactivated subunit vaccine (NFU1BHK) against type 2 herpes simplex virus infection, Med. Microbiol. Immunol. 166:119–132.
Smith, J. W., Adam, E., Melnick, J. L., and Rawls, W. E., 1972, Use of the 51Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2, J. Immunol. 109:554–564.
Smith, J. W., Toores, J. E., and Holmquist, N. D., 1979, Association of herpes simplex virus with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens, Am. J. Epidemiol. 110:141–147.
Sorice, F., 1971, La malattia erpetica, G. Mall. Infett. 23:469–546.
Spear, P., 1980, Composition and organization of herpesvirus virions and functions of the structural proteins, in: Oncogenic Herpesviruses (F. Rapp, ed.), CRC Press, Boca Raton VI pp. 53–84.
Spruance, S. L., Overall, J. C., Kern, E. R., Krueger, G. G., Pliam, V., and Miller, W., 1977, The natural history of recurrent herpes simplex labialis, N. Engl. J. Med. 297:69–75.
Stanwick, T., Campbell, D. E., and Nahmias, A. J., Spontaneous cytotoxicity mediated by human monocyte-macrophages against human fibroblasts infected with herpes simplex virus. Cell Immunol. 53:413–417.
Stanwick, T. L., Anderson, R. W., and Nahmias, A. J., 1977, Interaction between cyclic nucleotides and herpes simplex viruses — Productive infection. Infect. Immun. 18:342–347.
Starr, S. E., Karatela, S. A., Shore, S. L., Duffey, A. C., and Nahmias, A. J., 1975, Stimulation of human lymphocytes by herpes simplex virus antigens, Infect. Immun. 11:109–112.
Starr, S. E., Visintine, A. M., Tomeh, M. O., and Nahmias, A. J., 1976, Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection, Proc. Soc. Exp. Biol. Med. 152:57–60.
Steele, R. W., Hensen, S. A., Vincent, M. M., Fuccillo, D. A., Chapa, I. A., and Canales, L., 1975, Cellular immune responses to herpes simplex virus type 1 in recurrent herpes labialis: In vitro blastogenesis and cytotoxicity, J. Infect. Dis. 131:528–534.
Steele, R. W., Keeney, R. E., Brown, J., and Young, J., 1977, Cellular immune responses to herpesviruses during treatment with adenine arabinoside, J. Infect. Dis. 135:593–599.
Stevens, J. G., 1975, Latent herpes simplex virus and the nervous system, Curr. Top. Microbiol. Immunol. 70:31–50.
Stevens, J. G., and Cook, M. L., 1970, Restriction of herpes simplex virus by macrophages: An analysis of the cell-virus interaction. J. Exp. Med. 133:19–38.
Stevens, J. G., and Cook, M. L., 1974, Maintenance of latent herpetic infection: An apparent role for antiviral IgG, J. Immunol 113:1685–1693.
Stewart, J., and Nahmias, A., 1981, Laboratory diagnosis of herpes simplex viruses, in:Laboratory Diagnosis of Sexually Transmitted Diseases, A.P.H.A., Washington, D.C. (in press).
Stringfellow, D. A., Kern, E. R., Kelsey, D. K., and Glasgow, L. A., 1977, Suppressed response to interferon induction in mice infected with encephalomyocarditis virus, Semliki Forest virus, influenza A2 virus. Herpesvirus hominis type 2, or murine cytomegalovirus, J. Infect. Dis. 135: 540–551.
Strnad, B. C., and Aurelian, L., 1978, Proteins of herpesvirus 2. III. Isolation and immunologic characterization of a large molecular weight viral protein, Virology 87:401–415.
Strunk, R. C., John, T. J., and Sieber, O. F., 1977, Herpes simplex virus infections in guinea pigs deficient in the fourth component of complement. Infect. Immun. 15:165–168.
Subramanian, T., and Rawls, W. E., 1977, Compar ison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera, J. Clin. Microbiol. 5:551–558.
Sydiskis, R. J., and Schultz, I., 1966, Interferon and antibody production in mice with herpes simplex skin infection. J. Infect. Dis. 116:455–460.
Symoens, J., and Rosenthal, M., 1977, Levamisole in the modulation of the immune response: The current experimental and clinical state, J. Retic. Endothel. Soc. 21:175–221.
Teissier, P., Castinel, P., and Reilly, J., 1922, L’inoculabilité de l’herpes, C.R. Soc. Biol. 87:648–649.
Tevethia, S. S., Lowry, S., Rawls, W., Melnick, J., and McMillan, V., 1972, Detection of early cell surface changes in herpes simplex virus infected cells by agglutination with concanavalin A, J. Gen. Virol. 15:93–97.
Thiry, L., Sprecher-Goldberger, S., Fassin, Y., Gould, I., Gompel, C., Pestiau, J., and DeHalleux, F., 1974, Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix. Am. J. Epidemiol. 100:251–261.
Thiry, L., Sprecher-Goldberger, S., Hannecart-Pokorni, E., Gould, I., and Bossens, M., 1977, Specific non-immunoglobulin G antibodies and cell-mediated responses to herpes simplex virus antigens in women with cervical carcinoma. Cancer Res. 37:1301–1306.
Thong, Y. H., Vincent, M. M., Hensen, S. A., Fuccillo, D. A., Rola-Pleszczynski, M., and Bellanti, J. A., 1975, Depressed specific cell-mediated immunity to herpes simplex virus type 1 patients with recurrent herpes labialis. Infect. Immun. 12:76–80.
Tokamaru, T., 1966, A possible role of gamma A-immunoglobulin in herpes simplex virus infection in man, J. Immunol 97:248–259.
Tompkins, W. A. F., Seth, P., Gee, S., and Rawls, W. E., 1975, Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement, J. Immunol 116: 489–495.
Thompson, C. J., Docherty, J. J., Boltz, R. C., Gaines, R. A., and Todd, P., 1978, Electrokinetic alteration of the surface of herpes simplex virus infected cells, J. Gen. Virol. 39:449–461.
Trofatter, K. F., and Daniels, C. A., 1979, Interactions of human cells with prostaglandin cyclic AMP modulators, J. Immunol 122:1363–1370.
Trofatter, K. F., Daniels, C. A. Williams, R. J., and Gall S.A., 1979, Growth of type 2 herpes simplex virus in newborn and adult mononuclear leukocytes, Intervirology 11:117–123.
Valle, M. J., Jordan, G. W., Haahr, S., and Merigan, T. C., 1975, Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferon, J. Immunol 115:230–233.
Visintine, A. M., Nahmias, A. J., and Josey, W. E., 1978, Genital herpes. Perinatal Care 2:32–41.
Whitley, R. J., Nahmias, A. J., Visintine, A. M., Fleming, C. L., and Alford, C. A., 1980, The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 66:495–501.
Vos, G. H., Hammond, M. G., Vos, D., Grabbelar, B. G., Ansiander, H. P., and Marescotti, G., 1972, An evaluation of humoral antibody responses in patients with carcinoma of the cervix, J. Obstet. Gynecol. Br. Commun. 79:1040–1046.
Wallis, C., and Melnick, J. L., 1971, Herpesvirus neutralization: The role of complement, J. Immunol. 107:1235–1242.
Walz, M. A., Price, R. W., Hayashi, K., Katz, B. J., and Notkins, A. L., 1977, Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus type 1 and 2, J. Infect. Dis. 135:744–752.
Walz, M. A., Yamamoto, H., and Notkins, A. L., 1976, Immunological response restricts number of cells in sensory gangha infected with herpes simplex virus. Nature (London) 264:553–556.
Warren, K. G., Brown, S. M., Wroblewska, Z., Gilden, D., Koprowskin, H., and Subak-Sharpe, J., 1978, Isolation of latent herpes simplex virus from the superior cervical and vagus ganghons of human beings, N. Engl. J. Med. 298:1068.
Warren, K. G., Wroblewska, Z., Okabe, H., Brown, S. M., Gilden, D. H., Koprowski, H., Borke, B., Subak-Sharpe, J., and Yonezawa, L., 1978, Virology and histopathology of the trigeminal ganglia of Americans and Japanese, Can. J. Neurol. Sci. 5:425–430.
Willems, F. T. C., Melnick, J. L., and Rawls, W. E., 1969, Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis, Proc. Soc. Exp. Biol. Med. 130:652–661.
Wilton, J. M. A., Ivanyi, L., and Lehner, T., 1972, Cell-mediated immunity in herpesvirus hominis infections, Br. Med. J. 1:723–726.
Winter, H. A., Bryson, Y. J., Gard, S. E., Fischer, T. J., and Stiehm, E. R., 1978, Deficiency of monocyte migration inhibition factor and immune interferon production in lymphocytes of normal newborns, Pediat. Res. 12:488.
Wise, T. G., Pavan, P. R., and Ennis, F. A., 1977, Herpes simplex virus vaccine, J. Infect. Dis. 136:706–711.
Wutzler, P., Farber, I., and Ulbricht, A., 1978, Autoantibodies in herpesvirus infections, Acta Virol. 22:342.
Yamamoto, Y., 1966, A re-evaluation of the skin test of herpes simplex virus, Jpn. J. Microbiol. 10:67–77.
Yoshino, K., Hashimoto, M., and Shinkai, K., 1977, Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement, Microbiol. Immunol. 21:231–241.
Yoshino, K., and Taniguchi, S., 1964, The appearance of complement-requiring neutralizing antibodies by immunization and infection with herpes simplex virus, Virology 22:193–201.
Yoshino, K., and Taniguchi, S., 1966, Evaluation of the demonstration of complement-requiring neutralizing antibody as a means for early diagnosis of herpes virus infections, J. Immunol. 96:196–203.
Zaia, J. A., Leary, P. L., Levin, M. J., 1978, Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect. Immun. 20:646–651.
Zaia, J. A., Palmer, E. L., and Feorino, P., 1975, Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus, J. Infect. Dis. 132:660–666.
Zawatzky, R., Hilfenhaus, J., and Kirchner, H., 1979, Resistance of nude mice to herpes simplex virus and correlation with in vitro production of interferon. Cell. Immunol. 47:424–428.
Zinkernagel, R. M., and Doherty, P. C., 1977, Major transplantation antigens, viruses, and specificity of surveillance T cells, Contemp. Top. Immunobiol. 7:179–220.
Zisman, B., Hirsch, S., and Allison, A. C., Selective effects of anti-macrophage serum, silica and antilymphocyte serum on pathogenesis of herpes virus infection of young adult mice, J. Immunol. 104:1155–1165.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Shore, S.L., Nahmias, A.J. (1982). Immunology of Herpes Simplex Viruses. In: Nahmias, A.J., O’Reilly, R.J. (eds) Immunology of Human Infection. Comprehensive Immunology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1012-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1012-9_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1014-3
Online ISBN: 978-1-4684-1012-9
eBook Packages: Springer Book Archive